A “mix-and-use” approach for formulation of human clinical doses of 177 Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases-Reference-Cited by-同舟云学术

A “mix-and-use” approach for formulation of human clinical doses of 177 Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases

Published:2017-06-21 Issue:9 Volume:60 Page:410-419
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J. Label Compd. Radiopharm

Author:

Chakraborty Sudipta¹^ORCID,Vimalnath K.V.¹,Rajeswari A.¹,Chakravarty Rubel¹,Sarma H.D.²,Radhakrishnan E.³,Kamaleshwaran K.³,Shinto Ajit S.³,Dash Ashutosh¹

Affiliation:

1. Radiopharmaceuticals Division; Bhabha Atomic Research Centre (BARC); Mumbai India

2. Radiation Biology and Health Sciences Division; Bhabha Atomic Research Centre (BARC); Mumbai India

3. Nuclear Medicine and PET Services, Comprehensive Cancer Care Centre; Kovai Medical Centre and Hospital; Coimbatore India

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Reference26 articles.

1. Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases

2. Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with 223Ra-Dichloride

3. Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Quality Control, and Bench-to-Bed Translation of a New [⁶⁸Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography;Cancer Biotherapy and Radiopharmaceuticals;2024-02-01

2. Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production;Nuclear Medicine Communications;2023-02-21

3. Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions;Current Medicinal Chemistry;2020-06-04

4. Formulation of ‘ready-to-use’ human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using moderate specific activity 177Lu and its preliminary evaluation in human patient;Radiochimica Acta;2020-02-11

5. Ce-141-labeled DOTMP: A theranostic option in management of pain due to skeletal metastases;Journal of Labelled Compounds and Radiopharmaceuticals;2019-02-27